Cargando…

NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation

Cytokine-induced killer (CIK) cells are an ex vivo expanded heterogeneous cell population with an enriched NK-T phenotype (CD3+CD56+). Due to the convenient and relatively inexpensive expansion capability, together with low incidence of graft versus host disease (GVHD) in allogeneic cancer patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaolong, Sharma, Amit, Oldenburg, Johannes, Weiher, Hans, Essler, Markus, Skowasch, Dirk, Schmidt-Wolf, Ingo G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529192/
https://www.ncbi.nlm.nih.gov/pubmed/34691037
http://dx.doi.org/10.3389/fimmu.2021.731767
_version_ 1784586416665133056
author Wu, Xiaolong
Sharma, Amit
Oldenburg, Johannes
Weiher, Hans
Essler, Markus
Skowasch, Dirk
Schmidt-Wolf, Ingo G. H.
author_facet Wu, Xiaolong
Sharma, Amit
Oldenburg, Johannes
Weiher, Hans
Essler, Markus
Skowasch, Dirk
Schmidt-Wolf, Ingo G. H.
author_sort Wu, Xiaolong
collection PubMed
description Cytokine-induced killer (CIK) cells are an ex vivo expanded heterogeneous cell population with an enriched NK-T phenotype (CD3+CD56+). Due to the convenient and relatively inexpensive expansion capability, together with low incidence of graft versus host disease (GVHD) in allogeneic cancer patients, CIK cells are a promising candidate for immunotherapy. It is well known that natural killer group 2D (NKG2D) plays an important role in CIK cell-mediated antitumor activity; however, it remains unclear whether its engagement alone is sufficient or if it requires additional co-stimulatory signals to activate the CIK cells. Likewise, the role of 2B4 has not yet been identified in CIK cells. Herein, we investigated the individual and cumulative contribution of NKG2D and 2B4 in the activation of CIK cells. Our analysis suggests that (a) NKG2D (not 2B4) is implicated in CIK cell (especially CD3+CD56+ subset)-mediated cytotoxicity, IFN-γ secretion, E/T conjugate formation, and degranulation; (b) NKG2D alone is adequate enough to induce degranulation, IFN-γ secretion, and LFA-1 activation in CIK cells, while 2B4 only provides limited synergy with NKG2D (e.g., in LFA-1 activation); and (c) NKG2D was unable to costimulate CD3. Collectively, we conclude that NKG2D engagement alone suffices to activate CIK cells, thereby strengthening the idea that targeting the NKG2D axis is a promising approach to improve CIK cell therapy for cancer patients. Furthermore, CIK cells exhibit similarities to classical invariant natural killer (iNKT) cells with deficiencies in 2B4 stimulation and in the costimulation of CD3 with NKG2D. In addition, based on the current data, the divergence in receptor function between CIK cells and NK (or T) cells can be assumed, pointing to the possibility that molecular modifications (e.g., using chimeric antigen receptor technology) on CIK cells may need to be customized and optimized to maximize their functional potential.
format Online
Article
Text
id pubmed-8529192
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85291922021-10-22 NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation Wu, Xiaolong Sharma, Amit Oldenburg, Johannes Weiher, Hans Essler, Markus Skowasch, Dirk Schmidt-Wolf, Ingo G. H. Front Immunol Immunology Cytokine-induced killer (CIK) cells are an ex vivo expanded heterogeneous cell population with an enriched NK-T phenotype (CD3+CD56+). Due to the convenient and relatively inexpensive expansion capability, together with low incidence of graft versus host disease (GVHD) in allogeneic cancer patients, CIK cells are a promising candidate for immunotherapy. It is well known that natural killer group 2D (NKG2D) plays an important role in CIK cell-mediated antitumor activity; however, it remains unclear whether its engagement alone is sufficient or if it requires additional co-stimulatory signals to activate the CIK cells. Likewise, the role of 2B4 has not yet been identified in CIK cells. Herein, we investigated the individual and cumulative contribution of NKG2D and 2B4 in the activation of CIK cells. Our analysis suggests that (a) NKG2D (not 2B4) is implicated in CIK cell (especially CD3+CD56+ subset)-mediated cytotoxicity, IFN-γ secretion, E/T conjugate formation, and degranulation; (b) NKG2D alone is adequate enough to induce degranulation, IFN-γ secretion, and LFA-1 activation in CIK cells, while 2B4 only provides limited synergy with NKG2D (e.g., in LFA-1 activation); and (c) NKG2D was unable to costimulate CD3. Collectively, we conclude that NKG2D engagement alone suffices to activate CIK cells, thereby strengthening the idea that targeting the NKG2D axis is a promising approach to improve CIK cell therapy for cancer patients. Furthermore, CIK cells exhibit similarities to classical invariant natural killer (iNKT) cells with deficiencies in 2B4 stimulation and in the costimulation of CD3 with NKG2D. In addition, based on the current data, the divergence in receptor function between CIK cells and NK (or T) cells can be assumed, pointing to the possibility that molecular modifications (e.g., using chimeric antigen receptor technology) on CIK cells may need to be customized and optimized to maximize their functional potential. Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529192/ /pubmed/34691037 http://dx.doi.org/10.3389/fimmu.2021.731767 Text en Copyright © 2021 Wu, Sharma, Oldenburg, Weiher, Essler, Skowasch and Schmidt-Wolf https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wu, Xiaolong
Sharma, Amit
Oldenburg, Johannes
Weiher, Hans
Essler, Markus
Skowasch, Dirk
Schmidt-Wolf, Ingo G. H.
NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
title NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
title_full NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
title_fullStr NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
title_full_unstemmed NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
title_short NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
title_sort nkg2d engagement alone is sufficient to activate cytokine-induced killer cells while 2b4 only provides limited coactivation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529192/
https://www.ncbi.nlm.nih.gov/pubmed/34691037
http://dx.doi.org/10.3389/fimmu.2021.731767
work_keys_str_mv AT wuxiaolong nkg2dengagementaloneissufficienttoactivatecytokineinducedkillercellswhile2b4onlyprovideslimitedcoactivation
AT sharmaamit nkg2dengagementaloneissufficienttoactivatecytokineinducedkillercellswhile2b4onlyprovideslimitedcoactivation
AT oldenburgjohannes nkg2dengagementaloneissufficienttoactivatecytokineinducedkillercellswhile2b4onlyprovideslimitedcoactivation
AT weiherhans nkg2dengagementaloneissufficienttoactivatecytokineinducedkillercellswhile2b4onlyprovideslimitedcoactivation
AT esslermarkus nkg2dengagementaloneissufficienttoactivatecytokineinducedkillercellswhile2b4onlyprovideslimitedcoactivation
AT skowaschdirk nkg2dengagementaloneissufficienttoactivatecytokineinducedkillercellswhile2b4onlyprovideslimitedcoactivation
AT schmidtwolfingogh nkg2dengagementaloneissufficienttoactivatecytokineinducedkillercellswhile2b4onlyprovideslimitedcoactivation